This case highlights a unique molecular-pathological profile, suggesting NF1::SCAMP5 may define a provisional MPN subtype with distinct genetic features, warranting further study to elucidate its clinical significance. This evidence concerns the gene SCAMP5 and myeloproliferative disorder.